Marker Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of MRKR for the last quarter is 1.06 M USD, and it's 310.13% higher compared to the previous quarter. The net income of Q4 23 is -2.74 M USD.